Skip to main content

Post-IPO Equity Pharmaceutical Companies

Explore 204 pharmaceutical startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
204
Total Funding
$2.1B
Avg Funding
$85.8M
Cities
21

Export 204 Post-IPO Equity Pharmaceutical Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Houston, United States
$3.0M
raised

FibroBiologics is a regenerative medicine company developing an innovative solution for chronic disease treatment using fibroblast cells.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$1.4M
raised

BioNxt Solutions mission is to develop and commercialize next-generation pharmaceuticals.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$805.0M
raised

Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$6.1M
raised

Zelluna Immunotherapy is a privately owned Norwegian biopharmaceutical company.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Reykjavík, Iceland
$165.0M
raised

Alvotech is a biotechnology company that specializes in making biosimilars to create biologic medicines.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Toronto, Canada
$429K
raised

Avicanna is a biopharmaceutical company that focuses on the development of the medical cannabis space.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$75.0M
raised

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Charlottesville, United States
$32.0M
raised

Adial Pharmaceuticals develops prescription medications for addiction and related disorders.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$10.5M
raised

CervoMed a clinical-stage firm focused on discovering therapies for brain degenerative illnesses.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Gothenburg, Sweden
$1.6M
raised

Alzinova operates as a biotechnology company engaged in drug discovery research for Alzheimer’s disease.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Uppsala, Sweden
$22.4M
raised

Dicot Pharma, focused on drug discovery and development of a modern potency drug treating erectile dysfunction better than existing drugs.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Wilmington, United States
$22.3M
raised

NRx Pharmaceuticals is a pharmaceutical company developing therapeutics for the treatment of central nervous system disorders.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$1.0M
raised

A life sciences company focused on transformational medicine.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Pompano Beach, United States
$2.5M
raised

BioStem Technologies is engaged in the advancement of regenerative medicine and antiaging strategies.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$60.0M
raised

NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and neurodegenerative diseases.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Palm Beach Gardens, United States
$3.8M
raised

Jupiter Neurosciences is a biotechnology company that focuses on developing a treatment for Alzheimer and rare neurological disorders.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$115.0M
raised

Quince Therapeutics is developing treatments for Alzheimer's and other degenerative disorders.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Calgary, Canada
$5.0M
raised

XORTX Therapeutics is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Warren, United States
$3.0M
raised

Tevogen Bio develops immunotherapy solutions for treating cancer, neurological conditions, and viral infections.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Pennsylvania Furnace, United States
$250.0M
raised

ArriVent develops pharmaceutical products to cure presently untreatable cancer.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Zug, Switzerland
$132.3M
raised

Pharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$10.0M
raised

Eyenovia is a biopharmaceutical company that provides a portfolio of next generation topical eye treatments.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Houston, United States
$22.5M
raised

CNS Pharmaceutical is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Rockville, United States
$11.0M
raised

Shuttle Pharmaceuticals is a clinical-stage pharmaceutical company utilizing proprietary technology to develop novel therapies.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New Haven, United States
$384.4M
raised

VeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions.

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 26 to 50 of 204 companies

Ready to Connect with Post-IPO Equity Pharmaceutical Startups?

Get verified founder emails, funding details, and company data for 204 post-ipo equity pharmaceutical companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

204 Pharmaceutical Post-IPO Equity Startups (November 2026) — Page 2 | VCBacked